Safety and Efficacy Study of Combination Therapy With Cetuximab and FOLFOX4 in Patients With Colorectal Cancer
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine confirmed objective response rate to combination
therapy with cetuximab and FOLFOX4 or FOLFOX4 alone in patients with CRC and non-resectable
hepatic metastases
Phase:
Phase 2
Details
Lead Sponsor:
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)